Skip to main content

Table 5 Changes in Cystatin C and MD2 (ng/ml, mean ± SD) between the NPND group and the PND group

From: Effect of remote ischemic preconditioning on perioperative neurocognitive disorder in elderly patients undergoing major surgery and associated genetic variant analysis: a randomized clinical trial

  

NPND Group (n = 45)

PND Group (n = 45)

P value

Cystatin C

T0

572.6 ± 484.76

631.56 ± 695.04

0.642

 

T1

962.56 ± 474.51***

994.41 ± 530.08*

0.765

 

T3

820.71 ± 421.25*

822.71 ± 584.55

0.985

MD2

T0

7.28 ± 6.44

6.78 ± 7.35

0.735

 

T1

11.43 ± 6.37**

11.91 ± 7.91**

0.748

 

T3

9.84 ± 5.78

9.41 ± 6.76

0.749

  1. *P < 0.05
  2. **P < 0.01
  3. ***P < 0.001, compared with the preoperative group (T0)
Back to article page

Perioperative Medicine

ISSN: 2047-0525